Abstract |
The purpose of this study was to investigate the role of matrix metalloproteinase-9 (MMP-9) in the pathogenesis of vascular leakage in patients with dengue virus infection. Serum samples from 24 children with serologically confirmed dengue virus infection ( dengue fever [DF], 16; dengue hemorrhagic fever [DHF], 8; age, 9.5+/-2.4 years; 67% male] were analyzed for MMP-9 during the febrile and toxic stages and at follow-up. Serum samples obtained from 7 healthy children were used as controls. Serum MMP-9 levels in patients with dengue virus infection were found to be lower at the febrile (227.0+/-186.9 ng/ml) and toxic stages (150.9+/-151.7 ng/ml) than at follow-up (424.5+/-227.8 ng/ml) or in the control group (393.3+/-125.9 ng/ml, P<0.001 by one-way ANOVA). There was no significant difference between MMP-9 levels in patients with DHF and those with DF at any stage of the disease. In conclusion, MMP-9 levels are reduced during the febrile and toxic stages of dengue virus infection.
|
Authors | Nipasiri Voraphani, Apichai Khongphatthanayothin, Karakade Srikaew, Praewpilai Tontulawat, Yong Poovorawan |
Journal | Japanese journal of infectious diseases
(Jpn J Infect Dis)
Vol. 63
Issue 5
Pg. 346-8
(Sep 2010)
ISSN: 1884-2836 [Electronic] Japan |
PMID | 20859002
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Matrix Metalloproteinase 9
|
Topics |
- Analysis of Variance
- Case-Control Studies
- Child
- Dengue
(enzymology)
- Dengue Virus
- Female
- Fever
(enzymology, virology)
- Humans
- Male
- Matrix Metalloproteinase 9
(blood)
- Severe Dengue
(enzymology)
|